KR20190131926A - A drug for treating cold and its preparation method - Google Patents
A drug for treating cold and its preparation method Download PDFInfo
- Publication number
- KR20190131926A KR20190131926A KR1020180056955A KR20180056955A KR20190131926A KR 20190131926 A KR20190131926 A KR 20190131926A KR 1020180056955 A KR1020180056955 A KR 1020180056955A KR 20180056955 A KR20180056955 A KR 20180056955A KR 20190131926 A KR20190131926 A KR 20190131926A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- medicine
- medicament
- tablets
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 229940079593 drug Drugs 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title description 3
- 238000000034 method Methods 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 33
- 241000555712 Forsythia Species 0.000 claims description 15
- 239000003826 tablet Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 11
- 241001529821 Agastache Species 0.000 claims description 7
- 241001162994 Rugosus Species 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 7
- 239000007924 injection Substances 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 5
- 235000008397 ginger Nutrition 0.000 claims description 5
- 238000010411 cooking Methods 0.000 claims description 4
- 239000008298 dragée Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000007940 sugar coated tablet Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- -1 decoctions Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 235000014101 wine Nutrition 0.000 claims description 2
- 241000234314 Zingiber Species 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 235000010894 Artemisia argyi Nutrition 0.000 abstract 1
- 241001435059 Artemisia argyi Species 0.000 abstract 1
- 241001198934 Forsythia viridissima Species 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000009472 formulation Methods 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000005303 weighing Methods 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 244000273928 Zingiber officinale Species 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000007919 dispersible tablet Substances 0.000 description 2
- 239000002662 enteric coated tablet Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006186 oral dosage form Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000220436 Abrus Species 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000008589 Cortex Fraxini Substances 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AQLLBJAXUCIJSR-UHFFFAOYSA-N OC(=O)C[Na] Chemical compound OC(=O)C[Na] AQLLBJAXUCIJSR-UHFFFAOYSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Description
본 발명은 의약 분야, 특히 감기 치료용 의약과 그 제조방법에 관한 것이다.FIELD OF THE INVENTION The present invention relates to the field of medicine, in particular to medicines for the treatment of colds and methods for their preparation.
감기는 가장 흔한 급성 호흡기 감염성 질환이지만, 국내 또는 해외 자료를 살펴보면 일반 감기는 심각한 사회적 및 경제적 부담을 가져올 수 있고, 심각한 합병증을 유발할 수 있으며, 심지어 환자의 생명을 위협할 수 있어 일반 감기가 실제로 "일반적"인 것은 아니다.Cold is the most common acute respiratory infectious disease, but if you look at domestic or international data, it can be a serious social and economic burden, can cause serious complications, and can even endanger your life. It is not normal.
현재, 감기는 합리적인 식이요법, 적절한 양의 운동, 금연과 음주량의 제한 그리고 심리적 균형 또는 약물 치료와 함께 치료되고 있지만, 그 치료 효과는 이상적이지 않다. 게다가, 현재 의약들은 다른 독성들과 부작용들을 갖고 있다. 따라서 상기 결점들을 극복하기 위해 감기 치료용 신약이 절실히 필요한 상황이다.Currently, colds are treated with rational diets, adequate amounts of exercise, restrictions on smoking cessation and alcohol consumption, and psychological balance or medication, but the therapeutic effect is not ideal. In addition, current medications have other toxicities and side effects. Therefore, there is an urgent need for a new medicine for the treatment of colds to overcome the above drawbacks.
상기 문제점을 감안하여, 본 발명은 상기 문제점들 또는 최소한 상기 문제점의 일부를 해결할 수 있으며, 종래 의약들의 좋지 않은 치료 효과라는 결점을 극복할 수 있는 감기 치료용 의약을 제공한다.In view of the above problems, the present invention provides a medicine for treating colds which can solve the above problems or at least part of the above problems, and can overcome the drawback of the poor therapeutic effect of conventional medicines.
첫 번째 측면에 따르면, 본 발명은 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 포함하는 감기 치료용 의약을 제공한다.According to a first aspect, the present invention provides a medicament for treating colds comprising 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of Folium artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia. to provide.
두 번째 측면에 따르면, 본 발명은 하기의 단계들을 포함하는 상기 실시예 중 어느 하나에 따른 의약의 제조방법을 제공한다.According to a second aspect, the present invention provides a method of preparing a medicament according to any one of the above embodiments, comprising the following steps.
제1단계: 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 계량하는 단계;First step: 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of follum artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia;
제2단계: 상기 원료들을 달여 한약을 얻고, 상기 한약을 살균을 위해 압력솥으로 30 내지 60분간 조리하는 단계;Second step: decoction of the raw materials to obtain a Chinese medicine, cooking the Chinese medicine for 30 to 60 minutes in a pressure cooker for sterilization;
제3단계: 상기 결과물을 냉각하고, 100 내지 250 메쉬 여과포로 여과하고, 농축하여 걸쭉한 페이스트를 얻는 단계;Third step: cooling the resultant, filtering with 100-250 mesh filter cloth, and concentrating to obtain a thick paste;
제4단계: 상기 걸쭉한 페이스트를 건조 후, 분쇄하고, 체질하여 목적하는 의약을 얻는 단계.Fourth step: The thick paste is dried, pulverized and sieved to obtain a desired medicine.
본 발명은 감기 치료용 의약과 그의 제조방법을 개시한다. 본 발명에 따른 감기 치료용 의약은 종래의 의약들과는 다른 성분을 가지며, 종래의 의약들의 결점들을 극복할 수 있다.The present invention discloses a medicine for treating colds and a method of manufacturing the same. The medicine for treating colds according to the present invention has a different ingredient from the conventional medicines and can overcome the drawbacks of the conventional medicines.
이하 본 발명에 대해 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 일 실시예에서, 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 포함하는 감기 치료용 의약이 제공된다.In one embodiment of the present invention, 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of Folium artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia are provided. do.
또한, 상기 의약은 생강(fresh ginger) 20 내지 50중량부를 더 포함할 수 있다.In addition, the medicine may further comprise 20 to 50 parts by weight of ginger (fresh ginger).
또한, 상기 의약은 곽향(Agastache rugosus) 2 내지 22중량부를 더 포함할 수 있다.In addition, the medicine may further comprise 2 to 22 parts by weight of Agastache rugosus.
상기 생강(fresh ginger)과 곽향(Agastache rugosus)은 특정 예시에 불과하여 이에 제한되는 것은 아니며, 구기자(wolfberry fruit), 돌외(Gynostemma pentaphyllum), 사원자(Semen Astragali Complanati), 속단(Radix Dipsaci), 한련초(Herba Eclipta), 여정자(Fructus Ligustri Lucidi) 등과 같은 다른 재료들도 가능하다. 다른 가능한 재료들은 상세히 기술하지는 않는다.The fresh ginger and Agastache rugosus are not limited to these specific examples, but are not limited thereto. Wolfberry fruit, Gynostemma pentaphyllum, Semen Astragali Complanati, Radix Dipsaci, Other materials are also possible, such as Herba Eclipta and Fructus Ligustri Lucidi. Other possible materials are not described in detail.
선택적으로, 본 발명의 일 실시예에서, 강황(Curcuma longa), 천궁(Ligusticum chuanxiong Hort), 단삼(Radix Salviae Miltiorrhizae) 및 달맞이꽃(Evening Primrose)과 같은 혈액순환을 도와주는 재료들이 더 포함될 수 있다.Optionally, in an embodiment of the present invention, materials for aiding blood circulation, such as Curcuma longa, Ligusticum chuanxiong Hort, Radix Salviae Miltiorrhizae, Evening Primrose, may be further included.
또한, 본 발명의 일 실시예에서, 약리학적 효과를 증진시키기 위해 상기 의약은 치자(Fructus Gardeniae), 국화(Flos Chrysanthemi), 결명자(Semen Cassiae), 진피(Cortex Fraxini), 고삼(Radix Sophorae Flavescentis), 감국(Flos Chrysanthemi Indici), 천심련(Andrographis paniculata) 등과 같은 해열을 위한 재료들을 더 포함할 수 있다.In addition, in one embodiment of the present invention, in order to enhance the pharmacological effect, the medicament is Gardenia (Fructus Gardeniae), Chrysanthemum (Flos Chrysanthemi), Semen Cassiae, Cortex Fraxini, Radix Sophorae Flavescentis And it may further include materials for antipyretic, such as (Flos Chrysanthemi Indici), Andrographis paniculata.
또한, 상기 의약은 경천(Herba Sedi), 계골초(Abrus Herb) 등과 같은 축축한 기운(습)을 없애고, 이뇨 작용을 촉진시키는 재료들을 더 포함할 수 있다.In addition, the medicament may further include materials that eliminate moist energy (hum), such as Herba Sedi, Abrus Herb, and the like, and promote diuretic action.
또한, 상기 의약은 후추와 같은 내부를 따뜻하게 만드는 재료들을 더 포함할 수 있다.In addition, the medicament may further comprise materials that warm the interior, such as pepper.
본 발명의 일 실시예에서, 상기 의약의 제형은 필름피복정(film-coated tablet), 당피복정(sugar coated tablet), 장피복정(enteric coated tablet), 분산정(dispersible tablet), 캡슐, 과립, 탕약, 혼합물, 시럽, 약용 포도주(vinum), 주사제, 경구용 용액(oral solution) 및 경구용 현탁액(oral turbid liquid) 중 적어도 하나이다.In one embodiment of the present invention, the pharmaceutical formulation is a film-coated tablet (sugar-coated tablet), sugar coated tablet (sugar coated tablet), enteric coated tablet (enteric coated tablet), dispersible tablet, capsule, granules At least one of, medicinal herbs, mixtures, syrups, medicinal wines, injectables, oral solutions and oral turbid liquids.
본 발명의 일 실시예에서, 선택적으로, 상기 의약은 경구 투여 제형을 갖는다.In one embodiment of the invention, optionally, the medicament has an oral dosage form.
본 발명의 일 실시예에서, 선택적으로 상기 경구 투여 제형은 정제, 캡슐, 알약, 주사제, 서방형 제제(sustained release preparation) 및 조절된 방출 제제(controlled release preparation)를 포함한다.In one embodiment of the invention, optionally, the oral dosage form comprises tablets, capsules, pills, injections, sustained release preparations and controlled release preparations.
본 발명에서 제공되는 실시예의 의약 또는 의약 조성물은 장, 비강, 구강 점막, 눈, 폐, 호흡기, 피부, 직장 등을 통해 단위 제형으로 투여될 수 있고, 경구투여, 정맥주사, 근육주사 및 피하주사에 의해 투여될 수 있다.The medicament or pharmaceutical composition of the embodiments provided in the present invention may be administered in unit dosage form through the intestine, nasal cavity, oral mucosa, eyes, lungs, respiratory system, skin, rectum, and the like, oral administration, intravenous injection, intramuscular injection and subcutaneous injection. It can be administered by.
투여 제형은 액체 제형, 고체 제형 또는 반고체 제형일 수 있다. 상기 액체 제형은 용액, 유제, 현탁액, 주사제(물 주사, 분말 주사 및 수혈을 포함한다.), 점안제, 점비액, 로션 및 도포제일 수 있으며; 상기 고체 제형은 정제(비코팅 정제, 장피복정, 버칼정(buccal tablet), 분산정, 저작정(chewable tablet), 발포정(effervescent tablet), 경구 붕해형 정제(orally disintegrating tablet)를 포함한다.), 캡슐(경질 캡슐, 연질 캡슐, 장용성 캡슐(enteric capsule)을 포함한다.), 과립, 분말, 펠릿(pellet), 점적 환제(dropping pill), 좌약(suppository), 필름 제제(film agent), 페이스터(paster), 에어로졸(aerosol), 스프레이 등일 수 있으며; 상기 반고체 제형은 연고(ointment), 젤, 페이스트(paste) 등일 수 있다. 상기 의약의 제형은 바람직하게는 정제, 캡슐, 알약 그리고 주사제이다.Dosage formulations may be liquid, solid or semisolid formulations. The liquid formulations may be solutions, emulsions, suspensions, injections (including water injections, powder injections and transfusions), eye drops, nasal drops, lotions and applicators; Such solid formulations include tablets (uncoated tablets, enteric tablets, buccal tablets, dispersible tablets, chewable tablets, effervescent tablets, orally disintegrating tablets). ), Capsules (including hard capsules, soft capsules, enteric capsules), granules, powders, pellets, dropping pills, suppositories, film agents, May be paste, aerosol, spray, or the like; The semisolid formulation may be an ointment, a gel, a paste, or the like. The formulation of the medicament is preferably tablets, capsules, pills and injections.
본 발명의 일 실시예에 따른 상기 의약은 전통적인 제제, 서방형 제제, 조절된 방출 제제, 표적 제제 그리고 다양한 과립형 제제로 제조될 수 있다.The medicament according to one embodiment of the present invention may be prepared from traditional formulations, sustained release formulations, controlled release formulations, targeted formulations and various granular formulations.
본 발명의 일 실시예에서, 본 발명의 의약을 정제로 제조하기 위해 희석제(diluent), 결합제(binder), 습윤제(humectant), 붕해제(disintegrating agent), 윤활제(lubricant) 및 활택제(glidant)와 같은 다양한 부형제가 사용될 수 있다. 상기 희석제는 녹말, 덱스트린, 과당, 포도당, 젖당, 만니톨, 소르비톨, 자일리톨, 마이크로크리스탈린 셀룰로오스, 황산칼슘, 인산수소칼슘, 탄산칼슘 등일 수 있고; 상기 습윤제는 물, 에탄올, 이소프로판올 등일 수 있으며; 상기 결합제는 녹말 펄프, 덱스트린, 시럽, 꿀, 포도당 용액, 마이크로크리스탈린 셀룰로오스, 아라비아 고무 펄프, 젤라틴 펄프, 카르복시메틸 나트륨 셀룰로오스 또는 메틸 셀룰로오스일 수 있으며; 상기 붕해제는 건조된 녹말, 마이크로크리스탈린 셀룰로오스, 저치환된 하이드록시프로필 셀룰로오스일 수 있고; 상기 윤활제와 활택제는 탈크(talc), 실리카(silica), 스테아르산염, 액체 파라핀 등일 수 있다.In one embodiment of the invention, diluents, binders, humectants, disintegrating agents, lubricants and glidants for the preparation of the medicaments of the invention into tablets Various excipients such as can be used. The diluent may be starch, dextrin, fructose, glucose, lactose, mannitol, sorbitol, xylitol, microcrystalline cellulose, calcium sulfate, calcium hydrogen phosphate, calcium carbonate and the like; The wetting agent may be water, ethanol, isopropanol and the like; The binder may be starch pulp, dextrin, syrup, honey, glucose solution, microcrystalline cellulose, gum arabic pulp, gelatin pulp, carboxymethyl sodium cellulose or methyl cellulose; The disintegrant may be dried starch, microcrystalline cellulose, low substituted hydroxypropyl cellulose; The lubricant and lubricant may be talc, silica, stearate, liquid paraffin, or the like.
나아가, 상기 의약은 코팅된 정제일 수 있고, 예를 들면, 당피복정, 필름피복정, 장피복정 등일 수 있다.Furthermore, the medicine may be a coated tablet, for example, may be a sugar coating, a film coating, a long coat, and the like.
상기 의약이 캡슐로 제조될 경우, 유효 성분은 희석제, 결합제 및 붕해제가 첨가된 과립 또는 펠릿 형태로 제조될 수 있으며, 이들은 경질 캡슐 또는 연질 캡슐에 위치한다.If the medicament is prepared in capsules, the active ingredient may be prepared in the form of granules or pellets with added diluents, binders and disintegrants, which are located in hard capsules or soft capsules.
상기 의약이 주사제로 제조될 경우, 용매는 물, 에탄올, 이소프로판올, 프로필렌 글리콜, 또는 이들의 혼합물일 수 있다. 나아가, 적당한 양의 용해제, 공용매, pH 조절제, 삼투압 조절제가 첨가될 수 있다.When the medicament is prepared as an injection, the solvent may be water, ethanol, isopropanol, propylene glycol, or mixtures thereof. Furthermore, appropriate amounts of solubilizers, cosolvents, pH adjusters, osmotic pressure modifiers may be added.
또한, 상기 의약에 착색제(colorant), 방부제(presevative), 향료(perfume), 교정제(corrigent) 또는 다른 첨가물들이 첨가될 수 있다.In addition, colorants, presevatives, perfumes, corrigents or other additives may be added to the medicament.
본 발명의 일 실시예에서, 하기 단계들을 포함하는 상기 의약의 제조방법이 제공된다.In one embodiment of the present invention, there is provided a method of preparing the medicament comprising the following steps.
제1단계: 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 계량하는 단계;First step: 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of follum artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia;
제2단계: 상기 원료들을 달여 한약을 얻고, 상기 한약을 살균을 위해 압력솥으로 30 내지 60분간 조리하는 단계;Second step: decoction of the raw materials to obtain a Chinese medicine, cooking the Chinese medicine for 30 to 60 minutes in a pressure cooker for sterilization;
제3단계: 상기 결과물을 냉각하고, 100 내지 250 메쉬 여과포로 여과하고, 농축하여 걸쭉한 페이스트를 얻는 단계;Third step: cooling the resultant, filtering with 100-250 mesh filter cloth, and concentrating to obtain a thick paste;
제4단계: 상기 걸쭉한 페이스트를 건조하고, 분쇄하고, 체질하여 목적하는 의약을 얻는 단계.Fourth step: drying, grinding and sieving the thick paste to obtain the desired medicine.
이하, 상기 감기 치료용 의약의 제조방법의 몇 가지 특정한 예시를 제공한다.Hereinafter, some specific examples of the manufacturing method of the medicine for cold treatment are provided.
실시예Example
실시예Example 1 One
제1단계: 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 계량하고 이들을 혼합하여 혼합물을 얻는 단계;First step: weighing 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of Folium artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia and mixing them to obtain a mixture;
제2단계: 상기 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)의 혼합물에 적절한 양의 물을 첨가하고, 충분히 적셔질 때까지 8시간 동안 침지하는 단계;Second step: adding an appropriate amount of water to the mixture of Cortex lycii radicis, Folium artemisiae argyi and Fructus forsythia, and soaking for 8 hours until it is sufficiently wetted;
제3단계: 상기 혼합물에 생강 20g을 첨가한 후, 4시간 동안 30℃에서 가열하며, 매 30분마다 10ml의 물을 첨가하는 단계;Step 3: adding 20 g of ginger to the mixture, heating at 30 ° C. for 4 hours, and adding 10 ml of water every 30 minutes;
제4단계: 상기 혼합물을 4시간 동안 가열하고, 상온에 12시간 동안 두는 단계;Fourth step: heating the mixture for 4 hours, leaving at room temperature for 12 hours;
제5단계: 상기 혼합물을 100 내지 250 메쉬 여과포로 여과하고, 결과물을 농축하여, 걸쭉한 페이스트를 얻는 단계;Step 5: filtering the mixture through a 100 to 250 mesh filter cloth and concentrating the resultant to obtain a thick paste;
제6단계: 상기 걸쭉한 페이스트를 건조 후, 분쇄하고, 체질하여 목적하는 의약을 얻는 단계.6th step: The said thick paste is dried, pulverized and sieved to obtain a desired medicine.
실시예Example 2 2
제1단계: 곽향(Agastache rugosus), 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)를 계량하고, 이들을 혼합하여 혼합물을 얻는 단계;First step: weighing Agastache rugosus, Cortex lycii radicis, Folium artemisiae argyi, and Fructus forsythia, and mixing them to obtain a mixture;
제2단계: 상기 곽향(Agastache rugosus), 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)의 혼합물에 적절한 양의 물을 첨가하고, 충분히 적셔질 때까지 최소 8시간 동안 침지하는 단계;Step 2: Add an appropriate amount of water to the mixture of Agastache rugosus, Cortex lycii radicis, Folium artemisiae argyi, and Fructus forsythia, for at least 8 hours until it is sufficiently wetted. Dipping;
제3단계: 상기 혼합물에 행인(Semen Armeniacae Amarum) 20g을 첨가한 후, 4시간 동안 30℃에서 가열하며, 매 30분마다 10ml의 물을 첨가하는 단계;Step 3: After adding 20 g of Semen Armeniacae Amarum to the mixture, heating at 30 ° C. for 4 hours, and adding 10 ml of water every 30 minutes;
제4단계: 상기 혼합물을 4시간 동안 가열하고, 상온에 12시간 동안 두는 단계;Fourth step: heating the mixture for 4 hours, leaving at room temperature for 12 hours;
제5단계: 상기 혼합물을 100 내지 250 메쉬 여과포로 여과하고, 결과물을 농축하여 걸쭉한 페이스트를 얻는 단계;Step 5: filtering the mixture through a 100 to 250 mesh filter cloth and concentrating the resultant to obtain a thick paste;
제6단계: 상기 걸쭉한 페이스트를 건조 후, 분쇄하고, 체질하여 목적하는 의약을 얻는 단계.6th step: The said thick paste is dried, pulverized and sieved to obtain a desired medicine.
실시예Example 3 (과립의 제조방법) 3 (Manufacturing Method of Granules)
제1단계: 곽향(Agastache rugosus), 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)를 계량하고, 이들을 혼합하여 혼합물을 얻는 단계;First step: weighing Agastache rugosus, Cortex lycii radicis, Folium artemisiae argyi, and Fructus forsythia, and mixing them to obtain a mixture;
제2단계: 상기 곽향(Agastache rugosus), 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)의 혼합물에 적절한 양의 물을 첨가하고, 충분히 적셔질 때까지 최소 8시간 동안 침지하는 단계;Step 2: Add an appropriate amount of water to the mixture of Agastache rugosus, Cortex lycii radicis, Folium artemisiae argyi, and Fructus forsythia, for at least 8 hours until it is sufficiently wetted. Dipping;
제3단계: 상기 혼합물에 행인(Semen Armeniacae Amarum) 20g을 첨가하고, 4시간 동안 30℃에서 가열하며, 매 30분마다 10ml의 물을 첨가하는 단계;Step 3: adding 20 g of Semen Armeniacae Amarum to the mixture, heating at 30 ° C. for 4 hours, and adding 10 ml of water every 30 minutes;
제4단계: 상기 혼합물을 4시간 동안 가열하고, 상온에 12시간 동안 두는 단계;Fourth step: heating the mixture for 4 hours, leaving at room temperature for 12 hours;
제5단계: 상기 혼합물을 여과하여 여과물을 얻고, 여과물을 상대밀도 1.25(60℃)에서 감압 농축을 하여 추출물을 얻고, 추출물을 3배량의 덱스트린과 혼합하여 연질 물질을 얻은 후, 진동과립기로 과립을 제조하는 단계;Step 5: The mixture was filtered to obtain a filtrate, and the filtrate was concentrated under reduced pressure at a relative density of 1.25 (60 ° C.) to obtain an extract, and the extract was mixed with 3 times the amount of dextrin to obtain a soft substance. Preparing granules with a machine;
제6단계: 상기 과립을 65℃에서 30분 간 건조한 후, 과립을 다듬고, 작은 과립을 제거하기 위해 체질을 한 후, 포장하는 단계.Step 6: Drying the granules at 65 ° C. for 30 minutes, trimming the granules, sieving to remove small granules, and then packing.
실시예Example 4 (정제의 제조방법) 4 (Production method of the tablet)
제1단계: 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 계량하고 이들을 혼합하여 혼합물을 얻는 단계;First step: weighing 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of Folium artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia and mixing them to obtain a mixture;
제2단계: 상기 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)의 혼합물에 적절한 양의 물을 첨가하고, 충분히 적셔질 때까지 8시간 동안 침지하는 단계;Second step: adding an appropriate amount of water to the mixture of Cortex lycii radicis, Folium artemisiae argyi and Fructus forsythia, and soaking for 8 hours until it is sufficiently wetted;
제3단계: 상기 혼합물에 산약(Rhizoma Dioscoreae) 20g을 첨가한 후, 4시간 동안 30℃에서 가열하며, 매 30분마다 10ml의 물을 첨가하는 단계;Step 3: adding 20 g of Rhizoma Dioscoreae to the mixture, heating at 30 ° C. for 4 hours, and adding 10 ml of water every 30 minutes;
제4단계: 상기 혼합물을 4시간 동안 가열하고, 상온에 12시간 동안 두는 단계;Fourth step: heating the mixture for 4 hours, leaving at room temperature for 12 hours;
제5단계: 상기 혼합물을 여과하여 여과물을 얻고, 여과물을 상대밀도 1.25(60℃)에서 감압 농축을 하여 추출물을 얻고, 추출물을 3배량의 덱스트린과 혼합하여 연질 물질을 얻은 후, 진동과립기로 과립을 제조하는 단계;Step 5: The mixture was filtered to obtain a filtrate, and the filtrate was concentrated under reduced pressure at a relative density of 1.25 (60 ° C.) to obtain an extract, and the extract was mixed with 3 times the amount of dextrin to obtain a soft substance. Preparing granules with a machine;
제6단계: 상기 과립을 65℃에서 30분 간 건조한 후, single-punch tablet press를 사용하여 0.3g의 정제를 얻는 단계.Step 6: drying the granules at 65 ° C. for 30 minutes to obtain 0.3 g of tablets using a single-punch tablet press.
본 발명의 의약은 독립적으로 투여될 수도 있고, 다른 치료 의약들과 함께 사용될 수도 있다. 본 발명의 의약과 다른 치료 의약 간에 시너지 효과가 있는 경우, 본 발명의 의약의 투여량을 필요에 따라 조절할 수 있다. 상기 실시예들은 오직 설명을 위한 것일 뿐, 이에 제한되는 것은 아니다.The medicine of the present invention may be administered independently or may be used with other therapeutic medicines. If there is a synergy between the drug of the present invention and another therapeutic drug, the dosage of the drug of the present invention can be adjusted as necessary. The above embodiments are for illustrative purposes only and are not intended to be limiting.
실시예Example 5 5
제1단계: 지골피(Cortex lycii radicis), 애엽(Folium artemisiae argyi) 및 연교(Fructus forsythia)를 신중하게 선택 후, 세척하고, 특정 비율에 따라 계량하고, 균일하게 혼합하여 시작 재료를 얻는 단계;First step: carefully selecting Cortex lycii radicis, Folium artemisiae argyi, and Fructus forsythia, washing, weighing according to a specific ratio, and mixing uniformly to obtain starting material;
제2단계: 정수된 물에 상기 시작 재료를 첨가한 후, 결과물을 증기압력솥에서 1회에 40 내지 80분간 3 내지 4회 조리하여, 매 조리 시마다 걸쭉한 페이스트를 추출하고, 걸쭉한 페이스트를 100 내지 250 메쉬 여과포로 여과하는 단계;Step 2: After adding the starting material to purified water, the resultant is cooked in a steam pressure cooker for 3 to 4 times for 40 to 80 minutes at a time, extracting thick paste at every cooking, and thick paste 100 to 250 Filtering with mesh filter cloth;
제3단계: 상기 걸쭉한 페이스트들 전부를 모두 균일하게 혼합하는 단계;Step 3: uniformly mixing all the thick pastes;
제4단계: 상기 균일하게 혼합된 걸쭉한 페이스트들을 건조 후, 분쇄하고, 체질하여 목적하는 의약을 얻는 단계.Fourth step: Drying, grinding and sieving the uniformly mixed thick pastes to obtain the desired medicine.
Claims (5)
A medicament for treating colds comprising 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of Folium artemisiae argyi, and 3 to 20 parts by weight of Fructus forsythia.
The medicine for treating colds according to claim 1, further comprising 20 to 50 parts by weight of fresh ginger.
The medicament for treating colds according to claim 1, further comprising 2 to 22 parts by weight of Agastache rugosus.
The method of claim 1, wherein the dosage form of the medicament is at least one of a film coated tablets, sugar coated tablets, long tablets, dispersion tablets, capsules, granules, decoctions, mixtures, syrups, medicinal wines, injections, oral solutions and oral suspensions Medicine for the treatment of colds.
제1단계: 지골피(Cortex lycii radicis) 10 내지 20중량부, 애엽(Folium artemisiae argyi) 10 내지 15중량부 및 연교(Fructus forsythia) 3 내지 20중량부를 계량하는 단계;
제2단계: 상기 원료들을 달여 한약을 얻고, 상기 한약을 살균을 위해 압력솥에서 30 내지 60분 간 조리하는 단계;
제3단계: 상기 결과물을 냉각하고, 100 내지 250 메쉬 여과포로 여과하고, 농축하여 걸쭉한 페이스트를 얻는 단계;
제4단계: 상기 걸쭉한 페이스트를 건조 후, 분쇄하고, 체질하여 목적하는 의약을 얻는 단계.A method of preparing a medicament according to any one of claims 1 to 4, comprising the following steps:
First step: 10 to 20 parts by weight of Cortex lycii radicis, 10 to 15 parts by weight of follum artemisiae argyi and 3 to 20 parts by weight of Fructus forsythia;
Second step: decoction of the raw materials to obtain a Chinese medicine, cooking the Chinese medicine for 30 to 60 minutes in a pressure cooker for sterilization;
Third step: cooling the resultant, filtering with 100-250 mesh filter cloth, and concentrating to obtain a thick paste;
Fourth step: The thick paste is dried, pulverized and sieved to obtain a desired medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180056955A KR20190131926A (en) | 2018-05-18 | 2018-05-18 | A drug for treating cold and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180056955A KR20190131926A (en) | 2018-05-18 | 2018-05-18 | A drug for treating cold and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190131926A true KR20190131926A (en) | 2019-11-27 |
Family
ID=68729858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180056955A KR20190131926A (en) | 2018-05-18 | 2018-05-18 | A drug for treating cold and its preparation method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190131926A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0185538B1 (en) | 1996-12-05 | 1999-05-01 | 김춘란 | Complex coughing drug and their preparation method |
-
2018
- 2018-05-18 KR KR1020180056955A patent/KR20190131926A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0185538B1 (en) | 1996-12-05 | 1999-05-01 | 김춘란 | Complex coughing drug and their preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190131926A (en) | A drug for treating cold and its preparation method | |
KR20190115223A (en) | A drug for treating pharyngitis and its preparation method | |
KR20190115789A (en) | A drug for treating osteoporosis and its preparation method | |
KR20190083868A (en) | A drug for treating cold and its preparation method | |
KR20190094937A (en) | A drug for treating toothache and its preparation method | |
KR20190094870A (en) | A drug for treating cough and its preparation method | |
KR20190120879A (en) | A drug for treating cold and its preparation method | |
KR20190122982A (en) | A drug for treating shoulder periarthritis and its preparation method | |
KR20190134213A (en) | A drug for treating gastrohelcosis and its preparation method | |
DE102018105197A1 (en) | A MEDICAMENT FOR THE TREATMENT OF COSMETIC PAIN AND A METHOD FOR THE PRODUCTION THEREOF | |
KR20190121002A (en) | A drug for treating pharyngitis and its preparation method | |
KR20190139019A (en) | A drug for treating pharyngitis and its preparation method | |
KR20190103892A (en) | A drug for treating gout and its preparation method | |
KR20190132887A (en) | A drug for treating pharyngitis and its preparation method | |
KR20190117976A (en) | A Drug for Treating Toothache and its Preparation Method | |
KR20190094513A (en) | A drug for treating toothache and its preparation method | |
JP2019189587A (en) | Drug for treating cold and preparation method thereof | |
KR20190134210A (en) | A drug for treating osteoporosis and its preparation method | |
KR20190135175A (en) | A drug for treating pharyngitis and its preparation method | |
KR20190107871A (en) | A drug for treating gout and its prepration method | |
KR20190090451A (en) | A drug for treating toothache and its preparation method | |
KR20190115688A (en) | A drug for treating gastrohelcosis and its preparation method | |
KR20190093431A (en) | A drug for treating gout and its preparation method | |
KR20190108230A (en) | A drug for treating toothache and its preparation method | |
KR20190126571A (en) | A Drug for Treating Osteoporosis and its Preparation Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |